Physicians and medical students’ knowledge assessment in matters of classification and definition of arterial hypertension based on the multicenter PHYSTARH-II study results
https://doi.org/10.38109/2075-082X-2025-3-25-33
Abstract
Relevance. Arterial hypertension (AH) is a significant risk factor for cardiovascular diseases. Despite advancements in the diagnosis and treatment of AH, the level of knowledge among physicians and students remains insufficient, necessitating further study.
The aim of the study. To assess awareness of doctors and senior medical students regarding the definition, classification and diagnosis of arterial hypertension.
Materials and Methods. Data from the second phase of the PHYSTARH project (2019-2023) were analyzed – anonymous surveys of 494 physicians from 10 regions of Russian Federation and 426 students from 10 universities in Russian Federation and Kyrgyzstan. The questionnaire was based on clinical guidelines. The results were compared with data from 2017–2019. Statistical methods and tests used included the Kolmogorov-Smirnov test, Mann-Whitney U test, Kruskal-Wallis test, Pearson correlation, median test for independent samples, ANOVA modeling, and regression scatter plot analysis. Differences were considered significant at p-values <0.05.
Results. The overall level of knowledge proved to be insufficient. The average level of correctness (completeness) of answers (LCA) was 58.4% for students and 62.4% for physicians (compared to 49.4% and 55.3% in 2017-2019, respectively). The worst results were obtained in questions about home blood pressure monitoring and the definition of resistant, masked, and isolated ambulatory hypertension.
Conclusion. The knowledge of students and physicians regarding key aspects of arterial hypertension requires improvement. Additional educational programs are essential.
About the Authors
R. A. BontsevichRussian Federation
Roman A. Bontsevich, Cand. Sci. (Med.), Associate Professor, Department of Internal Diseases No. 2, Associate Professor, Department of Pharmacology and Clinical Pharmacology, Associate Professor, Department of Clinical Pharmacology and Pharmacotherapy, physician, pulmonologist, clinical pharmacologist
Lenin sq., 1, Yoshkar-Ola 424000, Mari El Republic
Pobedy st., 85, Belgorod 308015
st. Butlerova, 36, Kazan 420012
N. Sh. Kosimova
Russian Federation
Nargiza Sh. Kosimova, 5th year student
Lenin sq., 1, Yoshkar-Ola 424000, Mari El Republic
T. I. Chernyadyeva
Russian Federation
Tatyana I. Chernyadyeva, 6th year student
Lenin sq., 1, Yoshkar-Ola 424000, Mari El Republic
G. A. Batisheva
Russian Federation
Galina A. Batisheva, Dr. Sci. (Med.), Professor, Head of Department of Clinical Pharmacology
Studencheskaya st., 10, Voronezh 394036
V. A. Nevzorova
Russian Federation
Vera A. Nevzorova, Dr. Sci. (Med.), Professor, Head of the Institute of Therapy and Instrumental Diagnostic
Ostryakov avenue, 2, Vladivostok 690002
O. V. Tsygankova
Russian Federation
Oksana V. Tsygankova, Dr. Sci. (Med.), Professor, Department of Emergency Medicine with Endocrinology and Occupational Pathology, Faculty of Continuing Education and Professional Retraining of Doctors, Senior Researcher, Research Institute of Internal and Preventive Medicine, Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences
Krasny avenue, 52, Novosibirsk 630091
Boris Bogatkov st., 175/1, Novosibirsk 630089
G. G. Ketova
Russian Federation
Galina G. Ketova, Dr. Sci. (Med.), Professor, Department of Outpatient Therapy and Clinical Pharmacology
st. Vorovskogo, 64, Chelyabinsk 454092
G. G. Prozorova
Russian Federation
Galina G. Prozorova, Dr. Sci. (Med.), Professor, Department of therapeutic disciplines of the Institute of additional education
Studencheskaya st., 10, Voronezh 394036
O. G. Kompaniets
Russian Federation
Olga G. Kompaniets, Cand. Sci. (Med.), Associated Professor, Department of Therapy No. 1
Sedina st., 4, Krasnodar 350063
U. M. Tilekeeva
Kyrgyzstan
Ulankul M. Tilekeeva, Dr. Sci. (Med.), Professor Head of the Department of Basic and Clinical Pharmacology
Akhunbaev st., 92, Bishkek 720020
G. M. Bikkinina
Russian Federation
Guzel M. Bikkinina, Dr. Sci. (Med.), Professor, The Department of Pharmacology
Lenin st., 3, Ufa 450000
E. V. Luchinina
Russian Federation
Elena V. Luchinina, Cand. Sci. (Med.), Associated Professor of the Department of Department of Occupational Pathology, Hematology and Clinical Pharmacology
Bolshaya Kazachya st., 112, Saratov 410012
M. L. Maximov
Russian Federation
Maxim L. Maximov, Dr. Sci. (Med.), Professor, Head of the Department of Clinical Pharmacology and Pharmacotherapy, Professor, Department of Pharmacology, Dean of the Faculty of Preventive Medicine and Health Care Organization
st. Butlerova, 36, Kazan 420012
Barrikadnaya st., 2/1, building 1, Moscow 125993
Ostrovityanova st., 1, Moscow 117997
References
1. Kobalava Zh.D., Konradi A.O., Nedogoda S.V., et al. 2024 Clinical practice guidelines for Hypertension in adults. Russian Journal of Cardiology. 2024;29(9):6117. (In Russ.) https://doi.org/10.15829/1560-4071-2024-6117
2. Novak V.D., Haisheva L.A. Aspects of arterial hypertension in young adults with obesity. South Russian Journal of Therapeutic Practice. 2024;5(3):14-20. (In Russ.) https://doi.org/10.21886/2712-8156-2024-5-3-14-20
3. Balanova Yu.A., Kontsevaya A.V., Myrzamatova A.O., Mukaneeva D.K., Khudyakov M.B., Drapkina O.M. Economic Burden of Hypertension in the Russian Federation. Rational Pharmacotherapy in Cardiology. 2020;16(3):415-423. (In Russ.) https://doi.org/10.20996/1819-6446-2020-05-03
4. Bontsevich R.A., Vovk Y.R., Gavrilova A.A., et al. Knowledge of senior students in the definition, classification, and approaches to the treatment of arterial hypertension. Final results of the PHYSTARH project. Final results of the PHYSTARH project. Systemic Hypertension. 2021;18(4):169-17. https://doi.org/10.26442/2075082X.2021.4.200897
5. Bontsevich R.A., Vovk Y.R., Gavrilova A.A., et al. Etiopathogenesis, diagnosis, and approaches to the treatment of arterial hypertension: an assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project. Systemic Hypertension. 2021;18(1):25-30. (In Russ.) https://doi.org/10.26442/2075082X.2021.1.200346
6. Bontsevich R.A., Gavrilova A.A., Vovk Y.R., Adonina A.V., et al. The Assessment of Physicians’ and Senior Medical Students’ Knowledge in the Field of Community-Acquired Pneumonia: Preliminary Results of the KNOCAP-II Project (2017-2019). Medicni perspektivi. 2020; 25(1):59-65. https://doi.org/10.26641/2307-0404.2020.1.200402
7. Kobalava Zh.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):3786. (In Russ.) https://doi.org/10.15829/1560-4071-2020-3-3786
8. Williams B., Mancia G., Spiering W., et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH/ESC Task Force for the Management of Arterial Hypertension. Journal of Hypertension. 2018;36(12):2284-2309. https://doi.org/10.1097/HJH.0000000000001961
9. Chazova I.E., Zhernakova Yu.V. Diagnosis and treatment of arterial hypertension [Guidelines. Systemic Hypertension. 2019;16(1):6-31. (In Russ.) https://doi.org/10.26442/2075082X.2019.1.190179
10. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957-967. https://doi.org/10.1016/S0140-6736(15)01225-8
11. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/ PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):1269-1324. https://doi.org/10.1161/HYP.0000000000000066
12. Mancia G., Fagard R., Narkiewicz K., et al. Task Force Members, 2013. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens; 31(7):1281-357. PMID:23817082. https://doi.org/10.1097/01.hjh.0000431740.32696.cc
13. Williams B., Mancia G., Spiering W., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021-104. https://doi.org/10.1093/eurheartj/ehy339
14. Britov AN, Bystrova MM. Refractory hypertension – modern approaches to diagnostics and treatment. Rational Pharmacotherapy in Cardiology. 2010;6(2):206-211. (In Russ.). https://doi.org/10.20996/1819-6446-2010-6-2-206-211
15. Bontsevich R.A. Educational pharmacoepidemiology and "Real-World Knowledge". Real-World Data & Evidence. 2024;4(4):44-52. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-062
Review
For citations:
Bontsevich R.A., Kosimova N.Sh., Chernyadyeva T.I., Batisheva G.A., Nevzorova V.A., Tsygankova O.V., Ketova G.G., Prozorova G.G., Kompaniets O.G., Tilekeeva U.M., Bikkinina G.M., Luchinina E.V., Maximov M.L. Physicians and medical students’ knowledge assessment in matters of classification and definition of arterial hypertension based on the multicenter PHYSTARH-II study results. Systemic Hypertension. 2025;22(3):25-33. (In Russ.) https://doi.org/10.38109/2075-082X-2025-3-25-33



























